Scientists have combined two potent immunotherapies -- an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy -- to target and eradicate solid tumors that are otherwise difficult to treat with CAR T therapy alone.
from Latest Science News -- ScienceDaily https://ift.tt/3gYFkUu
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment